Today's Top Performers In Health Services

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 129 points (-0.8%) at 16,373 as of Friday, April 25, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 935 issues advancing vs. 2,039 declining with 150 unchanged.

The Health Services industry currently sits down 0.9% versus the S&P 500, which is down 0.6%. Top gainers within the industry include Tenet Healthcare ( THC), up 7.9%, and HCA Holdings ( HCA), up 3.6%. On the negative front, top decliners within the industry include PerkinElmer ( PKI), down 3.4%, Intuitive Surgical ( ISRG), down 1.6%, Aetna ( AET), down 1.3%, Thermo Fisher Scientific ( TMO), down 1.0% and UnitedHealth Group ( UNH), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. LifePoint Hospitals ( LPNT) is one of the companies pushing the Health Services industry higher today. As of noon trading, LifePoint Hospitals is up $2.67 (5.0%) to $56.18 on heavy volume. Thus far, 1.6 million shares of LifePoint Hospitals exchanged hands as compared to its average daily volume of 584,700 shares. The stock has ranged in price between $54.18-$57.13 after having opened the day at $54.18 as compared to the previous trading day's close of $53.51.

LifePoint Hospitals, Inc., through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States. LifePoint Hospitals has a market cap of $2.5 billion and is part of the health care sector. Shares are up 1.3% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts who rate LifePoint Hospitals a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates LifePoint Hospitals as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full LifePoint Hospitals Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Downgrade Won't Cure What Ails LifePoint Health

Downgrade Won't Cure What Ails LifePoint Health

Downgrade Won't Cure What Ails LifePoint Health

Why More Limbo on Healthcare Reform Is Bad News for Hospital Stocks

Hospitals Take Another Hit From Latest Senate Health Plan

Wall Street Weighs What's Next on Healthcare